Lymphoma Clinical Trials in Munich, Bavaria
4 recruitingMunich, Bavaria, Germany
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Leukemia RelapseLymphoma Diffuse Large B-cellLeukemia and Lymphoma+1 more
AvenCell Therapeutics, Inc.178 enrolled6 locationsNCT07284433
Recruiting
Phase 3
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Relapsed/Refractory Follicular LymphomaRelapsed/Refractory Marginal Zone Lymphoma (R/R MZL)
Regeneron Pharmaceuticals470 enrolled168 locationsNCT06149286
Recruiting
Phase 1Phase 2
[90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients
CNS Lymphoma
Pentixapharm AG15 enrolled2 locationsNCT06132737
Recruiting
Better Leukemia Diagnostics Through AI (BELUGA)
LymphomaMinimal Residual DiseaseLeukemia+2 more
Munich Leukemia Laboratory25,000 enrolled1 locationNCT04466059